Koers Lonza Group AG Swiss Exchange
Aandelen
CH0013841017
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- CHF | - |
14/05 | Zwitserse beursindex loopt op in aanloop naar inflatierapport | MT |
14/05 | Transcript : Lonza Group AG, Q1 2024 Earnings Call, May 14, 2024 |
Omzet 2024 * | 6,67 mld. 7,39 mld. 6,82 mld. | Omzet 2025 * | 7,7 mld. 8,53 mld. 7,87 mld. | Marktkapitalisatie | 35,08 mld. 38,85 mld. 35,82 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 893 mln. 989 mln. 912 mln. | Nettowinst (verlies) 2025 * | 1,11 mld. 1,23 mld. 1,13 mld. | EV/omzet 2024 * | 5,68 x |
Nettoschuld 2024 * | 2,83 mld. 3,13 mld. 2,89 mld. | Nettoschuld 2025 * | 3,53 mld. 3,9 mld. 3,6 mld. | EV/omzet 2025 * | 5,01 x |
K/w-verhouding 2024 * |
39,7
x | K/w-verhouding 2025 * |
31,7
x | Werknemers | - |
Dividendrendement 2024 * |
0,93% | Dividendrendement 2025 * |
1,08% | Vrij verhandelbaar | 96,79% |
Recentste transcriptie over Lonza Group AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25-04-17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01-12-21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16-04-14 |
Director/Board Member | 66 | 16-04-14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05-05-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 58,06 mld. | |
-5,31% | 40,53 mld. | |
+14,75% | 26,7 mld. | |
-12,56% | 26,56 mld. | |
-22,45% | 18,98 mld. | |
+0,04% | 12,17 mld. | |
+25,12% | 12 mld. | |
+26,04% | 11,92 mld. | |
-11,83% | 10,8 mld. |
- Beurs
- Aandelen
- Koers LONN
- Koers